The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
Abstract
A serious complication of aplastic anemia (AA) is its evolution to clonal hematologic diseases such as myelodysplasia (MDS) and leukemia, which is usually associated with the appearance of a cytogenetic abnormality in bone marrow cells. We present here an analysis of a cohort of 30 patients with otherwise typical AA in whom clonal karyotypic evolution was observed during frequent periodic marrow examinations. The actuarial risk for this complication has been estimated in other studies at around 15% at 5 years. Conversion from normal to abnormal karyotype occurred at a constant rate after initial diagnosis, with about 50% of cases developing within the first 30 months. Transient chromosomal abnormalities were infrequent. Clinically, AA patients with clonal cytogenetic patterns were heterogenous; a variety of karyotypic defects with numerical and structural abnormalities of chromosome 7 accounted for 40% of all cases followed by trisomy 8, structural and numerical abnormalities of chromosome 13, deletion of Y chromosome, and complex cytogenetic abnormalities. Unlike in primary MDS, aberrancies of chromosome 5 and 20 were infrequent. The clinical course depended on the specific abnormal cytogenetic pattern. Most deaths related to leukemic transformation occurred in patients with abnormalities of chromosome 7 or complex cytogenetic alterations or both. Evolution of chromosome 7 abnormalities was seen most often in refractory patients who had failed to respond to therapy. In contrast, trisomy 8 developed in patients with good hematologic responses who often required chronic immunosuppression with cyclosporine A (CsA), and survival was excellent. Although AA patients with monosomy 7 showed a similar prognosis to those with primary MDS, trisomy 8 in AA appears to have a more favorable prognosis than in MDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Camitta, B., Thomas, E., Nathan, D., Santos, G., Gordon-Smith, E., Gale, R., Rappeport, J., & Storb, R. (1976) · Blood · doi:10.1182/blood.v48.1.63.63 · Cited by 568
Malignant Tumors Occurring after Treatment of Aplastic Anemia
Socié, G., Henry-Amar, M., Bacigalupo, A. P., Hows, J., Tichelli, A., Ljungman, P. T., McCann, S. R., Frickhofen, N., Veer-Korthof, E. T. V., & Gluckman, É. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310143291603 · Cited by 458
Rosenfeld, S., Kimball, J., Vining, D., & Young, N. (1995) · Blood · doi:10.1182/blood.v85.11.3058.bloodjournal85113058 · Cited by 319
Self-citationParoxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes
Dunn, D. E., Tanawattanacharoen, P., Boccuni, P., Nagakura, S., Green, S. W., Kirby, M. R., Kumar, M. S. A., Rosenfeld, S., & Young, N. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-6-199909210-00002 · Cited by 279
Self-citationLate haematological complications in severe aplastic anaemia
Tichelli, A., Gratwohl, A. A., Würsch, A., Nissen, C., & SPECK, B. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb02382.x · Cited by 273
Bacigalupo, A. P., Brand, R., Oneto, R., Bruno, B., Sodé, G., Passweg, J. R., Locasciulli, A., Lint, M. T. V., Tichelli, A., McCann, S., et al. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90031-3 · Cited by 272
Solé, Espinet, Sanz, Cervera, Calasanz, Luño, Prieto, Granada, Hernández, Cigudosa, et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01868.x · Cited by 266
Kojima, S., Hibi, S., Kosaka, Y., Yamamoto, M., Tsuchida, M., Mugishima, H., Sugita, K., Yabe, H., Ohara, A., & Tsukimoto, I. (2000) · Blood · doi:10.1182/blood.v96.6.2049 · Cited by 253
The treatment of severe acquired aplastic anemia
Young, N., & Barrett, A. (1995) · Blood · doi:10.1182/blood.v85.12.3367.bloodjournal85123367 · Cited by 182
Self-citationLate clonal diseases of treated aplastic anemia
Socié, G., Rosenfeld, S., Frickhofen, N., Gluckman, E., & Tichelli, A. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90033-7 · Cited by 173
Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia.
Appelbaum, F. R., Barrall, J. L., Storb, R. F., Ramberg, R., Doney, K., Sale, G. E., & Thomas, E. D. (1987) · PubMed · Cited by 167
Clinical significance of Y chromosome loss in hematologic disease
Wiktor, A., Rybicki, B. A., Piao, Z. S., Shurafa, M., Barthel, B., Maeda, K., & Van Dyke, D. L. (2000) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200001)27:1<11::aid-gcc2>3.0.co;2-i · Cited by 165
Maciejewski, J. P., Follmann, D. A., Nakamura, R., Saunthararajah, Y., Rivera, C. E., Simonis, T. B., Brown, K. E., Barrett, J. A., & Young, N. S. (2001) · Blood · doi:10.1182/blood.v98.13.3513 · Cited by 156
Self-citationClinical significance of Y chromosome loss in hematologic disease
Wiktor, A. E., Rybicki, B. A., Piao, Z. S., Shurafa, M. S., Barthel, B. G., Maeda, K., & Dyke, D. L. V. (2000) · Genes Chromosomes and Cancer · Cited by 115
Suciu, S., Kuse, R., Weh, H. J., & Hossfeld, D. K. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90193-e · Cited by 114
The Myelodysplastic Syndromes: Pathobiology and Clinical Management
Bennett, J. M. (2007) · Cited by 96
Cytogenetic abnormalities in patients with severe aplastic anemia.
Mikhailova, N., Sessarego, M., Fugazza, G., Caimo, A., Filippi, S. D., Lint, M. T. V., Bregante, S., Valeriani, A., Mordini, N., Lamparelli, T., et al. (1996) · PubMed · Cited by 85
Fernandez, T. D. S., Ornellas, M. H., de Carvalho, L. O., Tabak, D. G., & Abdelhay, E. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00056-4 · Cited by 76
CYTOGENETIC ABNORMALITIES IN MULTIPLE MYELOMA
Fonseca, R., Coignet, L., & Dewald, G. W. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70119-2 · Cited by 25
Yamazaki, E., Kanamori, H., Taguchi, J., Harano, H., Mohri, H., & Okubo, T. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0138 · Cited by 18
Cited by
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Guidelines for the diagnosis and management of adult aplastic anaemia
Killick, S. B., Bown, N., Cavenagh, J., Dokal, I., Foukaneli, T., Hill, A., Hillmen, P., Ireland, R., Kulasekararaj, A., Mufti, G., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13853 · Cited by 749
Current concepts in the pathophysiology and treatment of aplastic anemia
Young, N. S., Calado, R. T., & Scheinberg, P. (2006) · Blood · doi:10.1182/blood-2006-03-010777 · Cited by 704
Self-citationEltrombopag Added to Standard Immunosuppression for Aplastic Anemia
Townsley, D. M., Scheinberg, P., Winkler, T., Desmond, R., Dumitriu, B., Rios, O., Weinstein, B., Valdez, J., Lotter, J., Feng, X., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613878 · Cited by 562
Self-citation
Metadata
- Authors
- Maciejewski, J. P., Risitano, A., Sloand, E. M., Nunez, O., & Young, N. S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-05-01
- Volume
- 99
- Issue
- 9
- Pages
- 3129-3135
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2015881261
- Cited by
- 252
- References
- 23
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.